碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组

金吾资讯06-04

金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2440741306?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-04 01:28","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2440741306","market":"us","top_or_hot":-1,"title":"碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组","media":"金吾资讯","content":"<div>\n<p>金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-04 01:28 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b><strong>金吾资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4567","symbol_name":"ESG概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","article_id":"2440741306","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2440741306","pubTimestamp":1717435701,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4567":"ESG概念","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","BK4588":"碎股","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4504":"桥水持仓","EW":"爱德华兹","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","BDX":"碧迪医疗","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4082":"医疗保健设备","BK4585":"ETF&股票定投概念"},"translate_title":"BD Medical (BDX) rose more than 2.6% to acquire Edward Life Sciences (EW) intensive care product group for US $4.2 billion in cash","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDX":1,"EW":1},"content_text":"金吾财讯 | 碧迪医疗(BDX)股价震荡走高，高见241.635美元，涨近4%，截至发稿，仍涨2.67%，报238.17美元，成交额2.41亿美元。日前，碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议，根据该协议，碧迪医疗将以42亿美元现金收购Edwards重症监护产品组，后者是先进监测解决方案的全球领导者，从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2440741306"}